Institute of Medical Genetics, Medical University of Vienna, Vienna, Austria.
Division of Obstetrics and Feto-Maternal Medicine, Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria.
Eur J Hum Genet. 2022 Apr;30(4):428-438. doi: 10.1038/s41431-021-01012-7. Epub 2022 Jan 1.
Exome sequencing has been increasingly implemented in prenatal genetic testing for fetuses with morphological abnormalities but normal rapid aneuploidy detection and microarray analysis. We present a retrospective study of 90 fetuses with different abnormal ultrasound findings, in which we employed the singleton exome sequencing (sES; 75 fetuses) or to a lesser extent (15 fetuses) a multigene panel analysis of 6713 genes as a primary tool for the detection of monogenic diseases. The detection rate of pathogenic or likely pathogenic variants in this study was 34.4%. The highest diagnostic rate of 56% was in fetuses with multiple anomalies, followed by cases with skeletal or renal abnormalities (diagnostic rate of 50%, respectively). We report 20 novel disease-causing variants in different known disease-associated genes and new genotype-phenotype associations for the genes KMT2D, MN1, CDK10, and EXOC3L2. Based on our data, we postulate that sES of fetal index cases with a concurrent sampling of parental probes for targeted testing of the origin of detected fetal variants could be a suitable tool to obtain reliable and rapid prenatal results, particularly in situations where a trio analysis is not possible.
外显子组测序已越来越多地应用于形态异常但正常快速非整倍体检测和微阵列分析的胎儿产前基因检测。我们对 90 例具有不同超声异常发现的胎儿进行了回顾性研究,其中我们使用了单胎外显子组测序(sES;75 例)或在较小程度上(15 例)使用了 6713 个基因的多基因panel 分析作为检测单基因疾病的主要工具。在这项研究中,致病性或可能致病性变异的检测率为 34.4%。最高的诊断率为 56%,见于多畸形胎儿,其次是骨骼或肾脏异常(分别为 50%的诊断率)。我们报告了 20 个不同已知疾病相关基因中的新致病变异和基因 KMT2D、MN1、CDK10 和 EXOC3L2 的新基因型-表型关联。根据我们的数据,我们假设对具有同时采集父母探针的胎儿索引病例进行 sES 靶向检测以检测检测到的胎儿变异的来源,可能是获得可靠和快速产前结果的合适工具,特别是在无法进行 trio 分析的情况下。